Webinar: Capsid titre quantification for AAV-based therapeutics
Cell and gene therapies require development of fit for purpose analytical tools to support bioprocess development, for biopharmaceutical characterization and lot release testing.
30Jan
Abacus dx Cancer Diagnostics – Breast Cancer
Breast cancer is the most common cancer affecting women in Australia and New Zealand1 and the second most commonly diagnosed cancer in Australia2.
24Jan
OriGen: Cryopreservation Accessories
Abacus dx offers a range of products from OriGen Biomedical for your cryopreservation and cell culture requirements.
24Jan
OriGen: Cryopreservation Bags
Abacus dx offers a range of products from OriGen Biomedical for your cryopreservation and cell culture requirements.
21Jan
Meet the Muse® – Tiny but Mighty
Meet your Muse® – a robust, compact, and affordable instrument for automated cell analysis.
21Jan
Vircell Universal Transport Medium
The success of virus diagnosis depends largely on the quality of the specimen and the conditions under which the specimen is transported and stored before being processed in the laboratory.
20Jan
Streck launches new blood collection tube
Abacus dx is pleased to announce the newest addition to Streck’s trusted blood collection tube portfolio, RNA Complete BCT™.
15Jan
Biocartis Launches Liquid Biopsy Idylla™ ctEGFR Mutation Assay (RUO)
Biocartis is pleased to announce the launch of the Idylla™ ctEGFR Mutation Assay (RUO1). This assay is the liquid biopsy version of the solid biopsy Idylla™ EGFR Mutation Test (CE-IVD).
14Jan
Vircell publication displayed in ECCMID 2018: Invasive Candidiasis
Invasive Candidiasis (IC) plays an important role as a severe infection hospital patients in intensive care, post-surgical and immunocompromised patients.